![Cureus | Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment | Article Cureus | Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment | Article](https://assets.cureus.com/uploads/figure/file/90324/lightbox_56873fb01c7f11ea967fe109aa9b495a-Figure-2_formatted_V1-PME.png)
Cureus | Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment | Article
![ZOMETA (zoledronic acid) for Hypercalcemia of Malignancy and Bone Metastases - Cancer Therapy Advisor ZOMETA (zoledronic acid) for Hypercalcemia of Malignancy and Bone Metastases - Cancer Therapy Advisor](https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2018/12/slide12111_1053447.jpg)
ZOMETA (zoledronic acid) for Hypercalcemia of Malignancy and Bone Metastases - Cancer Therapy Advisor
![Efficacy and safety of continued zoledronic acid every 4 weeks versus every 12 weeks in women with bone metastases from breast cancer Results of the OPTIMIZE-2 trial – OncoPrescribe Efficacy and safety of continued zoledronic acid every 4 weeks versus every 12 weeks in women with bone metastases from breast cancer Results of the OPTIMIZE-2 trial – OncoPrescribe](http://www.oncoprescribe.com/app/uploads/_1406171985.jpg)
Efficacy and safety of continued zoledronic acid every 4 weeks versus every 12 weeks in women with bone metastases from breast cancer Results of the OPTIMIZE-2 trial – OncoPrescribe
![Mechanism of action of abiraterone acetate, enzalutamide, radium-223... | Download Scientific Diagram Mechanism of action of abiraterone acetate, enzalutamide, radium-223... | Download Scientific Diagram](https://www.researchgate.net/publication/324912322/figure/fig4/AS:865472643862537@1583356166698/Mechanism-of-action-of-abiraterone-acetate-enzalutamide-radium-223-dichloride_Q640.jpg)
Mechanism of action of abiraterone acetate, enzalutamide, radium-223... | Download Scientific Diagram
![Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2212137420300725-gr3.jpg)
Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect
![Denosumab: mechanism of action and clinical outcomes - Hanley - 2012 - International Journal of Clinical Practice - Wiley Online Library Denosumab: mechanism of action and clinical outcomes - Hanley - 2012 - International Journal of Clinical Practice - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1f5b0bc0-32e9-4e7e-a668-784d55e0870f/ijcp_12022_f2.gif)
Denosumab: mechanism of action and clinical outcomes - Hanley - 2012 - International Journal of Clinical Practice - Wiley Online Library
![PDF] The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future. | Semantic Scholar PDF] The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/02ae3788787adf6a230ad8aee9e0cf256fd0f00b/2-Figure1-1.png)
PDF] The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future. | Semantic Scholar
![Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for Osteosarcoma | Bentham Science Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for Osteosarcoma | Bentham Science](http://www.eurekaselect.com/images/graphical-abstract/cdt/19/5/001.jpg)
Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for Osteosarcoma | Bentham Science
![Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment? | Breast Cancer Research | Full Text Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment? | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3223/MediaObjects/13058_2012_3048_Fig1_HTML.jpg)
Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment? | Breast Cancer Research | Full Text
![Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug | Scientific Reports Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-05553-0/MediaObjects/41598_2017_5553_Fig1_HTML.jpg)
Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug | Scientific Reports
![Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2212137420300725-gr1.jpg)
Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect
![Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF-1 pathway inhibition in vivo Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF-1 pathway inhibition in vivo](https://www.spandidos-publications.com/article_images/mmr/17/4/MMR-17-04-5470-g06.jpg)
Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF-1 pathway inhibition in vivo
![Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07568-9/MediaObjects/12885_2020_7568_Fig1_HTML.png)
Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text
![Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy | SpringerLink Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00198-007-0540-8/MediaObjects/198_2007_540_Fig8_HTML.gif)
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy | SpringerLink
![Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram](https://www.researchgate.net/profile/Andrew-Yee-7/publication/230850646/figure/fig1/AS:202882147196929@1425382281783/Mechanism-of-action-of-denosumab-compared-to-zoledronic-acid-Notes-RANKL-is-secreted-by_Q640.jpg)
Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram
![Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram](https://www.researchgate.net/publication/230850646/figure/fig1/AS:202882147196929@1425382281783/Mechanism-of-action-of-denosumab-compared-to-zoledronic-acid-Notes-RANKL-is-secreted-by.png)
Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram
![Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram](https://www.researchgate.net/profile/Pilar-Garrido-2/publication/280998264/figure/fig3/AS:284610790477826@1444867908479/figure-fig3_Q320.jpg)
Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram
![Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathways Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathways](https://www.spandidos-publications.com/article_images/mmr/25/2/mmr-25-02-12575-g06.jpg)
Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathways
![Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07568-9/MediaObjects/12885_2020_7568_Fig3_HTML.png)